Ofatumumab, a fully human anti-CD20 monoclonal antibody, in biological-naive, rheumatoid arthritis patients with an inadequate response to methotrexate: a randomised, double-blind, placebo-controlled clinical trial - Taylor, PC; Quattrocchi, E; Mallett, S (Ann Rheum Dis, 2011)
et al.